Get all your news in one place
100’s of premium titles. One news app. Zero ads. Just $10 per month.

Recap: Biohaven Pharma Hldgs Q1 Earnings


Biohaven Pharma Hldgs (NYSE:BHVN) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:50 AM.

Here's what investors need to know about the announcement.


Biohaven Pharma Hldgs beat estimated earnings by 35.97%, reporting an EPS of $-1.62 versus an estimate of $-2.53.

Revenue was up $275.03 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.28 which was followed by a 8.87% drop in the share price the next day.

Here's a look at Biohaven Pharma Hldgs's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -2.04 -2.40 -2.74 -2.82
EPS Actual -2.32 -1.91 -2.62 -2.97
Revenue Estimate 173.69M 128.40M 78.13M 40.63M
Revenue Actual 190.01M 135.74M 92.93M 43.82M

To track all earnings releases for Biohaven Pharma Hldgs visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.